COVID-19 is an understated watershed moment in U.S. national security, whereby a naturally-occurring virus has thrown individual citizens and the highest levels of leadership into disarray. The COVID-19 pandemic is driving perceptions of U.S. susceptibility to immensely disruptive biological threats and increases the likelihood of an artificial attack. This monumental shift in threat perception creates appealing circumstances for U.S. adversaries to experiment with emergent biotechnology.
The Temptations of the Brown Box
While harnessing technological improvements in the civilian sector to improve the capability of logistics, the U.S. military must proceed with caution. While many of the technologies––such as delivery drones and 3D printing––are in their nascent stages, asking important questions about the why, how, and in what context these technologies will be used might help alleviate future friction. U.S. strategists should be clear-eyed about what future logistics innovations can and cannot accomplish.